Results 211 to 220 of about 78,294 (297)
Eosinophilic bronchial inflammation can cause severe central bronchial narrowing and recurrent atelectasis, even in patients with well‐controlled asthma. Endobronchial biopsy can establish the diagnosis and identify this potentially reversible, corticosteroid‐responsive condition.
Ryusuke Kizawa +7 more
wiley +1 more source
Allopurinol-Induced Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) Syndrome: A Case Report and Review of the Published Evidence From India. [PDF]
Shinde A +4 more
europepmc +1 more source
Abstract A domestic shorthair cat was presented with lethargy and inappetence. Abdominal ultrasound revealed a large jejunal mural mass with diffuse wall thickening without loss of wall layering, severe jejunal lymphadenopathy, and moderate peritoneal effusion.
Riley Aronson +4 more
wiley +1 more source
A Rare Case of Minocycline-induced DIHS/DRESS with Predominant Pulmonary Involvement. [PDF]
Oiwa E +4 more
europepmc +1 more source
Long‐term survival after surgical removal of an intermediate grade pancreatic carcinoma in a cat
Abstract An 11‐year‐old male neutered domestic shorthair cat presented with a history of acute diarrhoea, decreased appetite, and a palpable abdominal mass. Following clinical staging and histopathological examination after partial pancreatectomy, the cat was diagnosed with a completely excised intermediate grade pancreatic carcinoma without evidence ...
Abel Verbrugghe +4 more
wiley +1 more source
Incidental finding of esophageal eosinophilia in patients investigated for suspected celiac disease: results from a pediatric retrospective study. [PDF]
Mandile R +4 more
europepmc +1 more source
Allopurinol-Induced Leukocytoclastic Vasculitis With Systemic Inflammatory Response: A Case Report From Azerbaijan. [PDF]
Ravikumar D, Silven G, Salimzade H.
europepmc +1 more source
Dermatologic Toxicities Associated With Novel Pan‐RAS/RAF Inhibitors
ABSTRACT Background The mitogen‐activated protein kinase (MAPK) pathway plays a key role in cell‐cycle regulation and tumor progression in cancer. Dermatologic toxicities (DTs) to newer pan‐RAS (RMC‐6236) and pan‐RAF (LXH254/naporafenib) inhibitors are emerging.
Lin J. He +11 more
wiley +1 more source

